129 related articles for article (PubMed ID: 30673774)
21. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.
Naimi HM; Rasekh H; Noori AZ; Bahaduri MA
BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146
[TBL] [Abstract][Full Text] [Related]
22. Restoration of sensitivity of a diverse set of drug-resistant Staphylococcus clinical strains by bactericidal protein P128.
Nair S; Poonacha N; Desai S; Hiremath D; Tuppad D; Mohan T; Chikkamadaiah R; Durgaiah M; Kumar S; Channabasappa S; Vipra A; Sharma U
J Med Microbiol; 2018 Mar; 67(3):296-307. PubMed ID: 29458674
[TBL] [Abstract][Full Text] [Related]
23. Effect of vancomycin and teicoplanin alone or in combination with fusidic acid or amikacin against methicillin-resistant staphylococci.
Roussel-Delvallez M; Wallet F; Barbiery P; Courcol RJ
J Chemother; 1997 Feb; 9(1):5-8. PubMed ID: 9106011
[TBL] [Abstract][Full Text] [Related]
24. Oritavancin retains bactericidal activity in vitro against standard and high inocula of heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA).
Arhin FF; Sarmiento I; Moeck G
Int J Antimicrob Agents; 2013 Apr; 41(4):397-8. PubMed ID: 23374976
[No Abstract] [Full Text] [Related]
25. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G
J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
[TBL] [Abstract][Full Text] [Related]
26. Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model.
LaPlante KL; Rybak MJ
Antimicrob Agents Chemother; 2004 Dec; 48(12):4665-72. PubMed ID: 15561842
[TBL] [Abstract][Full Text] [Related]
27. Biofilm Antimicrobial Susceptibility Increases With Antimicrobial Exposure Time.
Castaneda P; McLaren A; Tavaziva G; Overstreet D
Clin Orthop Relat Res; 2016 Jul; 474(7):1659-64. PubMed ID: 26797908
[TBL] [Abstract][Full Text] [Related]
28. The effect of inoculum size on selection of in vitro resistance to vancomycin, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus.
Rio-Marques L; Hartke A; Bizzini A
Microb Drug Resist; 2014 Dec; 20(6):539-43. PubMed ID: 25010140
[TBL] [Abstract][Full Text] [Related]
29. Cleistochlamys kirkii chemical constituents: Antibacterial activity and synergistic effects against resistant Staphylococcus aureus strains.
Pereira F; Madureira AM; Sancha S; Mulhovo S; Luo X; Duarte A; Ferreira MJ
J Ethnopharmacol; 2016 Feb; 178():180-7. PubMed ID: 26674158
[TBL] [Abstract][Full Text] [Related]
30. In-vitro antimicrobial activity of enoxacin in combination with eight other antibiotics against Pseudomonas aeruginosa, Enterobacteriaceae and Staphylococcus aureus.
Baltch AL; Bassey C; Fanciullo G; Smith RP
J Antimicrob Chemother; 1987 Jan; 19(1):45-8. PubMed ID: 3104277
[TBL] [Abstract][Full Text] [Related]
31. In vitro activities of vancomycin and linezolid against biofilm-producing methicillin-resistant staphylococci species isolated from catheter-related bloodstream infections from an Egyptian tertiary hospital.
Hashem AA; Abd El Fadeal NM; Shehata AS
J Med Microbiol; 2017 Jun; 66(6):744-752. PubMed ID: 28598310
[TBL] [Abstract][Full Text] [Related]
32. [Influence of inoculum size on MICs for methicillin-susceptible Staphylococcus aureus and methicillin-resistant Staphylococcus aureus].
Miyake N; Kadowaki M; Sato Y; Eriguchi Y; Nagasaki Y; Harada Y; Uchida Y; Shimono N
Jpn J Antibiot; 2011 Aug; 64(4):231-7. PubMed ID: 22066347
[TBL] [Abstract][Full Text] [Related]
33. Phage and Antibiotic Combinations Reduce
Joo H; Wu SM; Soni I; Wang-Crocker C; Matern T; Beck JP; Loc-Carrillo C
Viruses; 2023 Feb; 15(2):. PubMed ID: 36851674
[No Abstract] [Full Text] [Related]
34. Comparative activity of tedizolid and glycopeptide combination therapies for the treatment of Staphylococcus aureus infections: an in vitro and in vivo evaluation against strains with reduced susceptibility to glycopeptides.
Betts JW; Abdul Momin HF; Phee LM; Wareham DW
J Med Microbiol; 2018 Feb; 67(2):265-271. PubMed ID: 29300156
[TBL] [Abstract][Full Text] [Related]
35. Activity of amikacin, ertapenem, ciprofloxacin and levofloxacin alone and in combination against resistant nosocomial pathogens by time-kill.
Hosgor-Limoncu M; Ermertcan S; Tasli H; Yurtman AN
West Indian Med J; 2008 Mar; 57(2):106-11. PubMed ID: 19565951
[TBL] [Abstract][Full Text] [Related]
36. Observed Antagonistic Effect of Linezolid on Daptomycin or Vancomycin Activity against Biofilm-Forming Methicillin-Resistant Staphylococcus aureus in an In Vitro Pharmacodynamic Model.
Luther MK; LaPlante KL
Antimicrob Agents Chemother; 2015 Dec; 59(12):7790-4. PubMed ID: 26369963
[TBL] [Abstract][Full Text] [Related]
37. Activity of glycopeptides in combination with amikacin or rifampin against Staphylococcus epidermidis biofilms on plastic catheters.
Pascual A; Ramirez de Arellano E; Perea EJ
Eur J Clin Microbiol Infect Dis; 1994 Jun; 13(6):515-7. PubMed ID: 7957277
[TBL] [Abstract][Full Text] [Related]
38. EFFECT OF LINEZOLID ALONE AND IN COMBINATION WITH OTHER ANTIBIOTICS, ON METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS.
Yehia H; El Said M; Azmy M; Badawy M; Mansy S; Gohar H; Madany N
J Egypt Soc Parasitol; 2016 Apr; 46(1):57-66. PubMed ID: 27363041
[TBL] [Abstract][Full Text] [Related]
39. In vitro elution and antibacterial activity of clindamycin, amikacin, and vancomycin from R-gel polymer.
Thomas LA; Bizikova T; Minihan AC
Vet Surg; 2011 Aug; 40(6):774-80. PubMed ID: 21770984
[TBL] [Abstract][Full Text] [Related]
40. [Contribution of bactericidal rate in the initial treatment of severe staphylococcal infections in children].
Bingen E; Lambert-Zechovsky N; Beaufils F; Mercier JC; Cohen R; Roze JC
Arch Fr Pediatr; 1988 Jan; 45(1):61-4. PubMed ID: 3365107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
